Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) Enterprise Value: 2009-2024

Historic Enterprise Value for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to -$348.5 million.

  • Pediatrix Medical's Enterprise Value fell 11006.89% to -$463.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$463.1 million, marking a year-over-year decrease of 11006.89%. This contributed to the annual value of -$348.5 million for FY2024, which is 9607.3% down from last year.
  • Latest data reveals that Pediatrix Medical reported Enterprise Value of -$348.5 million as of FY2024, which was down 9607.3% from -$177.7 million recorded in FY2023.
  • In the past 5 years, Pediatrix Medical's Enterprise Value registered a high of -$103.1 million during FY2022, and its lowest value of -$1.2 billion during FY2020.
  • Its 5-year average for Enterprise Value is -$468.9 million, with a median of -$348.5 million in 2024.
  • As far as peak fluctuations go, Pediatrix Medical's Enterprise Value plummeted by 57358.32% in 2020, and later skyrocketed by 7883.29% in 2022.
  • Over the past 5 years, Pediatrix Medical's Enterprise Value (Annual) stood at -$1.2 billion in 2020, then soared by 60.37% to -$486.9 million in 2021, then surged by 78.83% to -$103.1 million in 2022, then tumbled by 72.46% to -$177.7 million in 2023, then crashed by 96.07% to -$348.5 million in 2024.
  • Its last three reported values are -$348.5 million in FY2024, -$177.7 million for FY2023, and -$103.1 million during FY2022.